Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1992 Nov 15;147(10):1477–1488.

Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.

A B Miller 1, C J Baines 1, T To 1, C Wall 1
PMCID: PMC1336544  PMID: 1423088

Abstract

OBJECTIVE: To evaluate the efficacy of annual mammography over and above annual physical examination of the breasts and the teaching of breast self-examination among women aged 50 to 59 on entry. DESIGN: Individually randomized controlled trial. SETTING: Fifteen urban centres in Canada with expertise in the diagnosis and treatment of breast cancer. PARTICIPANTS: Women with no history of breast cancer and no mammography in the previous 12 months were randomly assigned to undergo either annual mammography and physical examination (MP group) or annual physical examination only (PO group). The 39,405 women enrolled from January 1980 through March 1985 were followed for a mean of 8.3 years. DATA COLLECTION: Derived from the participants by initial and annual self-administered questionnaires, from the screening examinations, from the patients' physicians, from the provincial cancer registries and by record linkage to the Canadian National Mortality Data Base. Expert panels evaluated histologic and death data. MAIN OUTCOME MEASURES: Rates of referral from screening, rates of detection of breast cancer from screening and from community care, nodal status, tumour size and rates of death from all causes and from breast cancer. RESULTS: Over 85% of the women in each group attended the screening sessions after screen 1. The characteristics of the women in the two groups were similar. Compared with the Canadian population the participants were more likely to be married, have fewer children, have more education, be in a professional occupation, smoke less and have been born in North America. The rate of screen-detected breast cancer on first examination was 7.20 per 1000 in the MP group and 3.45 per 1000 in the PO group, more node-positive tumours were found in the MP group than in the PO group. At subsequent screens the detection rates were a little less than half the rates at screen 1. During years 2 through 5 the ratios of observed to expected cases of invasive breast cancer were 1.28 in the MP group and 1.18 in the PO group. Of the women with invasive breast cancer through to 7 years, 217 in the MP group and 184 in the PO group had no node involvement, 66 and 56 had one to three nodes involved, 32 and 34 had four or more nodes involved, and 55 and 46 had an unknown nodal status. There were 38 deaths from breast cancer in the MP group and 39 in the PO group. The ratio of the proportions of death from breast cancer in the MP group compared with those in the UC group was 0.97 (95% confidence interval 0.62 to 1.52). The survival rates were similar in the two groups. Women whose cancer had been detected by mammography alone had the highest survival rate. CONCLUSION: The study was internally valid, and there was no evidence of randomization bias. Screening with yearly mammography in addition to physical examination of the breasts detected considerably more node-negative, small tumours than screening with physical examination alone, but it had no impact on the rate of death from breast cancer up to 7 years' follow-up from entry.

Full text

PDF
1477

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson I., Aspegren K., Janzon L., Landberg T., Lindholm K., Linell F., Ljungberg O., Ranstam J., Sigfússon B. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ. 1988 Oct 15;297(6654):943–948. doi: 10.1136/bmj.297.6654.943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baines C. J. Impediments to recruitment in the Canadian National Breast Screening Study: response and resolution. Control Clin Trials. 1984 Jun;5(2):129–140. doi: 10.1016/0197-2456(84)90119-3. [DOI] [PubMed] [Google Scholar]
  3. Baines C. J., McFarlane D. V., Miller A. B. Sensitivity and specificity of first screen mammography in 15 NBSS centres. Can Assoc Radiol J. 1988 Dec;39(4):273–276. [PubMed] [Google Scholar]
  4. Baines C. J., Miller A. B., Kopans D. B., Moskowitz M., Sanders D. E., Sickles E. A., To T., Wall C. Canadian National Breast Screening Study: assessment of technical quality by external review. AJR Am J Roentgenol. 1990 Oct;155(4):743–749. doi: 10.2214/ajr.155.4.2119103. [DOI] [PubMed] [Google Scholar]
  5. Baines C. J., Miller A. B., Wall C., McFarlane D. V., Simor I. S., Jong R., Shapiro B. J., Audet L., Petitclerc M., Ouimet-Oliva D. Sensitivity and specificity of first screen mammography in the Canadian National Breast Screening Study: a preliminary report from five centers. Radiology. 1986 Aug;160(2):295–298. doi: 10.1148/radiology.160.2.3523590. [DOI] [PubMed] [Google Scholar]
  6. Baines C. J., To T. Changes in breast self-examination behavior achieved by 89,835 participants in the Canadian National Breast Screening Study. Cancer. 1990 Aug 1;66(3):570–576. doi: 10.1002/1097-0142(19900801)66:3<570::aid-cncr2820660327>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  7. Baker L. H. Breast Cancer Detection Demonstration Project: five-year summary report. CA Cancer J Clin. 1982 Jul-Aug;32(4):194–225. doi: 10.3322/canjclin.32.4.194. [DOI] [PubMed] [Google Scholar]
  8. Collette H. J., Day N. E., Rombach J. J., de Waard F. Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study. Lancet. 1984 Jun 2;1(8388):1224–1226. doi: 10.1016/s0140-6736(84)91704-5. [DOI] [PubMed] [Google Scholar]
  9. Day N. E., Baines C. J., Chamberlain J., Hakama M., Miller A. B., Prorok P. UICC project on screening for cancer: report of the workshop on screening for breast cancer. Meeting held in Helsinki, Finland, on April 7-9, 1986. Int J Cancer. 1986 Sep 15;38(3):303–308. doi: 10.1002/ijc.2910380302. [DOI] [PubMed] [Google Scholar]
  10. Frisell J., Eklund G., Hellström L., Lidbrink E., Rutqvist L. E., Somell A. Randomized study of mammography screening--preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat. 1991 Mar;18(1):49–56. doi: 10.1007/BF01975443. [DOI] [PubMed] [Google Scholar]
  11. McLelland R., Pisano E. D. The politics of mammography. Radiol Clin North Am. 1992 Jan;30(1):235–241. [PubMed] [Google Scholar]
  12. Miller A. B., Baines C. J., Sickles E. A. Canadian National Breast Screening Study. AJR Am J Roentgenol. 1990 Nov;155(5):1133–1134. doi: 10.2214/ajr.155.5.2120947. [DOI] [PubMed] [Google Scholar]
  13. Miller A. B., Howe G. R., Wall C. The National Study of Breast Cancer Screening Protocol for a Canadian Randomized Controlled trial of screening for breast cancer in women. Clin Invest Med. 1981;4(3-4):227–258. [PubMed] [Google Scholar]
  14. Palli D., Del Turco M. R., Buiatti E., Carli S., Ciatto S., Toscani L., Maltoni G. A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer. 1986 Oct 15;38(4):501–504. doi: 10.1002/ijc.2910380408. [DOI] [PubMed] [Google Scholar]
  15. Roberts M. M., Alexander F. E., Anderson T. J., Chetty U., Donnan P. T., Forrest P., Hepburn W., Huggins A., Kirkpatrick A. E., Lamb J. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet. 1990 Feb 3;335(8684):241–246. doi: 10.1016/0140-6736(90)90066-e. [DOI] [PubMed] [Google Scholar]
  16. Schechter M. T., Miller A. B., Baines C. J., Howe G. R. Selection of women at high risk of breast cancer for initial screening. J Chronic Dis. 1986;39(4):253–260. doi: 10.1016/0021-9681(86)90047-0. [DOI] [PubMed] [Google Scholar]
  17. Shapiro S., Strax P., Venet L. Periodic breast cancer screening in reducing mortality from breast cancer. JAMA. 1971 Mar 15;215(11):1777–1785. [PubMed] [Google Scholar]
  18. Simard A., Paquette L., Baillargeon J., Falardeau M. Perception of cancer detection and early treatment in a population participating in the National Breast Screening Study in Canada. Can J Public Health. 1989 May-Jun;80(3):226–227. [PubMed] [Google Scholar]
  19. Tabár L., Akerlund E., Gad A. Five-year experience with single-view mammography randomized controlled screening in Sweden. Recent Results Cancer Res. 1984;90:105–113. doi: 10.1007/978-3-642-82031-1_14. [DOI] [PubMed] [Google Scholar]
  20. Tabár L., Fagerberg C. J., Gad A., Baldetorp L., Holmberg L. H., Gröntoft O., Ljungquist U., Lundström B., Månson J. C., Eklund G. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985 Apr 13;1(8433):829–832. doi: 10.1016/s0140-6736(85)92204-4. [DOI] [PubMed] [Google Scholar]
  21. Verbeek A. L., Hendriks J. H., Holland R., Mravunac M., Sturmans F. Mammographic screening and breast cancer mortality: age-specific effects in Nijmegen Project, 1975-82. Lancet. 1985 Apr 13;1(8433):865–866. doi: 10.1016/s0140-6736(85)92223-8. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES